32 results about "Intestinal bacterium" patented technology

The present invention provides a mulberry pomace chicken feed and a preparation method thereof. The mulberry pomace chicken feed comprises the following raw materials in weight percentage: 20-30% of mulberry pomace powder, 10-15% of corn flour, 10-12% of rice bran, 4-8% of molasses, 10-15% of soybean meal powder, 10-15% of wheat bran, 5-8% of mulberry leaf powder, 8-12% of mulberry branches, 1-5% of atractylodes lancea, 2-4% of mirabilite, 5-8% of dried orange peels, 2-3% of ammonium sulfate, 0.2-0.5% of monopotassium phosphate and 0.05-0.08% of magnesium sulfate. The provided chicken feed is rich in raw material variety and adequate in nutrition, and is free of any chemical medicines. The feed after fermentation is fragrant in smell, is high in protein content, and is good in palatability. The food intake of chicken flocks is increased, the growth and development of chicken is fast, and the daily weight gain of chicken is increased significantly. The chicken feed can improve the production performance of chicken, significantly improve the intestinal environment of chicken, promote intestinal bacterium growth and reproduction, and inhibit the growth of harmful bacteria.

The invention discloses a microbial fermentation feed for litopenaeus vannamei. The microbial fermentation feed is prepared by the following specific steps: after fully mixing photosynthetic bacteria and bacillus, adding brown sugar and uniformly mixing to obtain a mixture A; uniformly spraying the mixture A on a commercially available feed for litopenaeus vannamei to obtain a mixture B; filling the mixture B in a sealed container, and sealing at a normal temperature for fermenting, wherein the fermentation is completed when the temperature of the center of the sealed container rises to 45 DEG C; and taking out a fermented mixture B, air-drying and bagging to obtain the microbial fermentation feed for the litopenaeus vannamei. The microbial fermentation feed for the litopenaeus vannamei, provided by the invention, is suitable for a later charging amount rapid-increasing stage during aquaculture of the litopenaeus vannamei, and is a health care functional feed product which has the functions of increasing the feed utilization rate and the digestibility, protecting the liver of the litopenaeus vannamei and promoting the intestinal bacterium equilibrium.

The invention aims to provide a traditional Chinese medicine for treating and / or preventing gastrointestinal dysfunction caused by critical diseases. The traditional Chinese medicine is prepared from the following raw materials: radix codonopsis, fried largehead atractylodes rhizome, poria cocos, honey-fried licorice root, Chinese yam, white hyacinth bean, coix seed, villous amomum fruit, balloonflower root, pomegranate rind, myrobalan, and red halloysite. The traditional Chinese medicine is prepared according to the theories of tonifying qi, invigorating the spleen, upbearing the clear, and downbearing the turbid, has an integral conditioning effect by simultaneously eliminating and supplementing; can promote the peristalsis and propulsion of gastrointestinal smooth muscle, improves the blood circulation of the intestinal walls, reduces the capillary permeability of the gastrointestinal tracts, relieves the tissue edema, promotes the discharge of dead tissues, inhibits the intestinal bacterium translocation and toxin absorption in the intestines, eliminates the free radicals, and antagonizes the system inflammation reaction. The traditional Chinese medicine for treating gastrointestinal dysfunction caused by critical diseases has a good effect, can control the incidence rate of gastrointestinal dysfunction below 19.05%, does not have any side or toxic effect during the clinical process, and is reliable and safe.

The invention discloses application of bacteria in preparation of a synergist of an immune checkpoint inhibitor. According to the present invention, the human endogenous intestinal bacterium single bacterium oral preparation is combined with the immune checkpoint inhibitor, and the anti-tumor immune protection reaction is generated through the endogenous intestinal bacterium stimulation, such that the drug effect of the immune checkpoint inhibitor on a plurality of tumor species is significantly enhanced, the safety is good, the overall survival time of cancer patients is prolonged, and the treatment effect is good. The response rate of cancer immunotherapy crowds is improved, and cancer immunotherapy benefiting tumor patient crowds are expanded.

With the aim of providing an anti-bacterial composition against oral bacteria, and the like, that induce proliferation or activation of Th1 cells in the intestinal tract, it was discovered that bacteria that restrict colonisation of the intestinal tract, and the like, by the oral bacteria, and the like, are among the intestinal flora. Moreover, the intestinal bacteria that restrict intestinal colonisation, and the like, by the oral bacteria, and the like, were successfully isolated.

The present invention relates to a composition and a healthy food product for induced bowel movement and diet comprising 47-57 parts by weight of a psyllium husk powder, 18-28 parts by weight of a rice bran powder, 5-6 parts by weight of a kelp powder, 4-5 parts by weight of a fructooligosaccharide, 3.5-4.5 parts by weight of chicory fiber, 3-4 parts of weight of glasswort, 2.5-3.5 parts by weightof yeast powder, 1.5-2.5 parts by weight of lactulose powder, 0.5-1.5 parts by weight of lactic acid bacteria powder, 0.05-0.15 parts by weight of a complex amino acid, 0.4-0.6 parts by weight of aloe avoresence, and 0.5-1.5 parts by weight of garlic powder. The composition and healthy food product for induced bowel movement and diet of the present invention comprise nutritional ingredients suchas vegetable dietary fiber, vitamins, minerals, etc. which are fed to beneficial intestinal bacteria, thereby activating beneficial intestinal bacteria, increasing a proportion of beneficial bacteriain the intestinal flora, and promoting intestinal metabolism to induce bowel movements and prevent the occurrence of intestinal toxins.

The invention belongs to the field of biology, and specifically discloses Bacillus Velez D2406 isolated from the intestinal tract of soldier flies and its application. The preservation number of the Bacillus Velez is CCTCC NO: M2020874. fly growth, and can stably inhibit Staphylococcus aureus in vitro and in soldier fly larvae. The intestinal bacterium of the invention can increase the conversion rate of larvae, increase the reduction rate of materials, increase the weight gain rate of larvae, and stably inhibit Staphylococcus aureus in the isolated condition and in soldier fly larvae. The volatile compound 2,5-dimethylpyrazine produced by the bacteria has a significant inhibitory effect on zoonotic pathogenic bacteria. Inoculation of the intestinal bacteria into the Soldier Fly transformation system not only improved the transformation efficiency of Soldier Fly larvae, but also reduced the abundance of Staphylococcus aureus in the transformation material, and it is expected to reduce the incidence of bacteria brought about by the use of chemical drugs. environmental pollution.

The invention discloses a primer pair and a kit for detecting butyryl-CoA: acetate CoA transferase (butyryl-CoA: acetate CoA transferase) synthesis gene. Based on the screening of a butyrate synthesis gene from the intestinal bacterium Alistipes putredinis that is highly expressed in the human body (named but gene), its gene sequence is shown in SEQ ID NO.1, and a specific and quantitative effect was found Ideal primer pair combination, and designed detection kit. The invention effectively overcomes the deficiencies of the prior art in the detection of colorectal cancer (CRC) risk genes in intestinal bacteria, and can improve the prediction rate of CRC diseases. The kit of the invention is suitable for all types of fluorescence quantitative gene amplification instruments currently on the market, has high sensitivity, fast and accurate quantification, good stability, good application prospects, and high industrial utilization value.

The present invention provides an oral composition for potentiating the production of equol by an intestinal bacterium which contains, as the active ingredient, difructose anhydride for activating the equol productivity of the intestinal bacterium.

The present invention relates to a novel species of Enterobacter, Enterobacter sp. 638, and to increased plant growth, e.g. Use of methods of growing, increasing plant biomass, increasing plant fruit and / or seed productivity, increasing plant disease tolerance and / or resistance and increasing plant drought tolerance and / or drought resistance. The method includes applying to the plant an effective amount of a composition comprising an isolated culture of Enterobacter 638.

A method of preparing 1, 3- propylene glycol by high cell density intestinal uses the method of fermentation. Its process: seed culturing the intestinal bacterium is activated and then inoculated in the nutrient solution with no bacterium seed; the raises process of fermentation nutrient solution: when this solution is disinfected and cool, we inoculate the seed solution with the volume rate 3-15% into a tank of fermentation solution; the fast grow period of separated fermentation solution: the density of carbon retains 0.1-30g / L; high cell density fermentation period: the density of the bacterium seed reaches OD6502.0-5.0; it adapts the way of limited accommodate of alimentation and air; when the product has been synthesized, we add nitrogen, phosphate, inorganic ion, trace element,VB12 or their mixture of one or several components, and simultaneously add flowing glycerin; when there is acid, the fermentation process finishes.

The present invention provides a method for screening for a food ingredient or a food composition that reduces a cancer risk and inhibits cancer development. A substance that reduces a cancer risk is screened by administering a candidate substance and analyzing alteration in gut microbiota or a metabolite produced by an intestinal bacterium. Also, candidate substances are screened by adding each candidate substance to a bacterial culture system and analyzing its effect on a bacterium involved in cancer development.

The present invention provides a method capable of detecting a cancer and / or a carcinogenic risk, and a reagent for the detection thereof. The present invention also provides a method for screening for a pharmaceutical drug for reducing a carcinogenic risk and a pharmaceutical composition. Since cancer development closely correlates with alteration in gut microbiota, cancer development and / or a risk of cancer development are detected by detecting alteration in gut microbiota and a secondary bile acid produced by an intestinal bacterium. The present invention further provides a method for screening for a pharmaceutical drug with a gut microbiota as an index, and a pharmaceutical composition.

An antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria containing intestinal bacteria as an active ingredient or a pharmaceutical composition for treating, improving, or preventing infectious disease and inflammatory disease, etc.

Gene chip for inspecting enteric important pathomycete, its inspection and reagent kit are disclosed. The gene chip consists of solid-phase carrier and oligonucleotide probe fixed on the carrier, which comprises at least one DNA fragment selected from oligose unit treating enzyme gene or glycosylation transferring enzyme of intestinal bacterium O-antigen gene cluster and DNA fragment selected fromcolon bacillus 16S rRNA conservative area, Multiplex PCR amplifying for gene set DNA to be inspected by primer, hybridizing with the gene chip, analyzing and appraising by software Bactarray Analyzer. It's efficient and fast, and has excellent sensitivity and specificity. It can be used to discriminate blood serum type and used in science life, medical inspection, food safety, import-export quarantine.